✦ LIBER ✦

Bi-weekly administration of capecitabine + oxaliplatin (XELOX-2) in first line treatment of advanced colorectal cancer (ACRC): Preliminary results

✍ Scribed by M. Di Bisceglie; G. Di Maggio; F. Giuliani; V. Lorusso; S. Cinieri; G. Colucci; E. Maiello

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronomodulated administration of oxalip

✍ Daniele Santini; Bruno Vincenzi; Gaia Schiavon; Marisa Di Seri; Vladimir Virzí; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Capecitabine in combination with oxalipl

✍ Twelves, C.; Butts, C.; Cassidy, J.; Conroy, Th.; DeBraud, F.; Díaz-Rubio, E.; F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Bevacizumab + folfiri as first

✍ F. Giuliani; V. Lorusso; F. De Vita; S. Cinieri; E. Maiello; I. Nugnes; S. del P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Bi-weekly administration of capecitabine&#xa0;+&#xa0;oxaliplatin (XELOX-2) in first line treatment of advanced colorectal cancer (ACRC): Preliminary results